SCHEMBL7302855

SCHEMBL7302855

O=c1[nH]c(=O)n(CCCCN2CC=C(c3ccccc3)CC2)c2ccc(Cl)cc12

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 14/20 0.64
SIGMAR1 Q99720 1/20 0.53
DRD2 P14416 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308221 0.92 PARP1 (0.63) PARP1SIGMAR1
SCHEMBL7307656 0.88 PARP1 (0.63) PARP1DRD2
SCHEMBL7307433 0.88 PARP1 (0.62) PARP1SIGMAR1
SCHEMBL7305161 0.88 PARP1 (0.73) PARP1
Bromide SCHEMBL7309634 0.87 PARP1 (0.62) PARP1DRD2
Hydrochloric Acid SCHEMBL7301868 0.87 PARP1 (0.62) PARP1
SCHEMBL7303980 0.86 PARP1 (0.60) PARP1
SCHEMBL7303316 0.85 PARP1 (0.64) PARP1DRD2
SCHEMBL7301646 0.85 PARP1 (0.59) PARP1SIGMAR1
Bromide SCHEMBL7303725 0.84 PARP1 (0.63) PARP1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed